logo
How California's farmers can recharge the aquifers they've drained

How California's farmers can recharge the aquifers they've drained

Yahoo02-05-2025

In parts of California's Central Valley, so much groundwater has been pumped out of the ground to deal with the region's persistent drought that the land is starting to sink in. Underground aquifers — layers of sand, gravel, clay, and water — are vital resources that communities can turn to when surface water is scarce. But when more water is pumped out of aquifers than is put back in — as is happening in the southern part of the valley — it can cause the ground to slowly contract, like a drying sponge.
After studying this phenomenon, Rosemary Knight, a professor of geophysics at the Stanford Doerr School of Sustainability, became interested in identifying the fastest ways to replenish California's groundwater using managed aquifer recharge. This technique involves flooding a piece of land with excess surface water and allowing that water to seep through the ground and into aquifers, where it can be stored for later use. Armed with a massive electromagnetic dataset, Knight and a team of researchers set out to analyze sediment types below the surface in the California Central Valley and map out the quickest routes to refilling aquifers.
Their research, published last month in the journal Earth and Space Science, found that between 2 million and 7 million acres of land in the Central Valley are suitable for recharge — or between 19 and 56 percent of the valley's total area. Most of the rechargeable land is currently used to grow crops. Many farmers are enthused about the data, according to Knight — and keen to implement it. As climate change continues to exacerbate water challenges in California, her team's research points to how agricultural producers can help to ensure sustainable water access for all. 'They want to be part of the solution,' said Knight.
Since 2000, the U.S. Southwest has been in the driest 25-year period the region has seen in over a millennium, according to researchers at the University of California, Los Angeles, who found that climate change has supercharged these dry conditions. Part of the way rising global temperatures exacerbate water challenges is by increasing the evaporation of surface water, or water in rivers, lakes, and reservoirs. Scientists are also eyeing how climate change could impact snowpack in the Sierra Nevada mountain range, which forms a critical part of California's annual water supply every spring as it melts and moves into rivers and streams. In 2015, a multiyear drought in California led to an unprecedented decline in snowpack in the Sierra Nevada; researchers have also predicted that global warming could cause snowlines on the Sierra Nevada to rise towards the end of the century, meaning snow would only form at higher elevations, reducing the overall amount of snow on the mountain range.
Water is critical for the region because the Central Valley is an agricultural powerhouse, producing one-fourth of the nation's food, according to the U.S. Geological Survey. It's home to more than 250 different crops — from hay and cotton to rice and corn to tomatoes and olives. But the state's agricultural industry has also been blamed for depleting groundwater while wells run dry in nearby rural communities. Over the past two decades, groundwater levels in California have been steadily falling, despite aquifers being periodically recharged naturally by snowmelt and rainfall, according to a 2022 study in Nature Communications.
'Natural recharge was not keeping pace with the rate of extraction,' said Knight.
In order to determine how water would flow through sediments below the ground, Knight and her colleagues used a large set of electromagnetic data acquired by the California Department of Water Resources. The data was collected by helicopters flying over the Central Valley in a grid formation, with flightlines spaced a few miles apart. Using special equipment that sends an electromagnetic signal into the ground, the choppers were able to determine how the current is conducted through layers of soil at a depth of up to 300 meters. Areas full of coarse materials like sand and gravel — where water flows seamlessly — can't conduct electricity easily.
By interpreting these results, the researchers were able to construct a 3D model of the subsurface and pinpoint 'fastpaths' for water to travel down into aquifers.
This kind of information could be vital for regional California agencies, which have been instructed to develop plans for using groundwater more efficiently under the state's Sustainable Groundwater Management Act. The data that Knight and her colleagues produced — which they've made available online — can also help agricultural producers decide whether or not to implement groundwater recharge on their lands. Their analysis reveals which specific croplands are best suited for recharging aquifers (like the ones used to grow fruits, nuts, and field crops, as well as vineyards) and which aren't (those used for rice and citrus).
This level of soil data can help farmers make decisions about whether managed recharge is right for their land. 'Growers really want to have confidence that if their land is being flooded for recharge, that water is going to very rapidly move below the ground surface,' said Knight. Better guidance for agricultural producers has already been circulating; the Almond Board of California has been recommending groundwater recharge for a few years now and published an introductory guide for growers.
Christine Gemperle, a longtime almond grower who sits on the Almond Board of California, has flooded one of her orchards twice for groundwater recharge — and said she has seen numerous benefits beyond raising groundwater levels in her area. They include flushing gophers out of her fields (they love her cover crops, Gemperle said) and pushing salts that accumulate from irrigation further down into the soil. Although she wasn't able to do it this winter, due to dry conditions lowering the amount of surface water available, she feels optimistic that this kind of data can empower other farmers to explore recharge. 'There's so much opportunity,' she said.
Like many farmers in the state, Gemperle already had access to canals that transport water from a reservoir to her fields for irrigation. This made recharge fairly straightforward: When she saw the canals were full of water during a particularly wet year, she got permission from her local irrigation district to open the canal gates and flood her land. The prevalence of this kind of infrastructure is an advantage for California farmers interested in recharge, according to Shimon Anisfeld, a professor at the Yale School of the Environment focused on water management who was not involved in Knight's study.
Managed recharge can provide some 'environmental win-wins,' said Anisfeld. When farmers face wet winters and dry summers, recharge can help store excess surface water, making it accessible during the growing season. In certain instances, like when farmlands are restored into floodplains, aquifer recharge can also double as habitat restoration for wildlife.
Farmers are likely to be motivated to dedicate some of their land to aquifer recharge, said Anisfeld, especially if they can reap the benefits later.
Still, he suggested, Californians will likely need to tackle its water challenges by decreasing demand as much as boosting supply. 'I'm not convinced that recharge is going to be a substitute for reducing water use,' he said. 'I don't think it can, on its own, solve the whole problem.' Managed aquifer recharge may be a more attractive option for farmers than the alternative of changing their agricultural practices. 'If you can recharge groundwater, that gives you more to work with,' Anisfeld said. 'It means you can keep on farming and keep on growing water-intensive crops.'
Knight agreed that growers don't 'want to stop pumping' groundwater or have to fallow their fields. She hopes that by publishing a version of their data online and making it accessible to the public, her team will help empower individual stakeholders to explore the options that are best for their soil.
'I care about actionable data presented in a way that is helpful to end users, such as growers, managers of water districts,' she said. That way, 'the user can make their own decisions about how best to use the results.'
As for Gemperle, she sees flooding her farmland as a way to ensure that her community continues to have access to water. 'I see it as something that really points to how connected we are in this agricultural landscape,' she said. 'We are more connected than disconnected.'
This story was originally published by Grist with the headline How California's farmers can recharge the aquifers they've drained on May 2, 2025.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

California scientists sound alarm on role of pesticides in raising resistance to antifungal drugs
California scientists sound alarm on role of pesticides in raising resistance to antifungal drugs

Yahoo

time3 hours ago

  • Yahoo

California scientists sound alarm on role of pesticides in raising resistance to antifungal drugs

The proliferation of new fungicides in the U.S. agricultural sector may be raising resistance to critical antifungal medications in humans and animals, infectious disease experts are warning. Although antifungal pesticides have become vital to combatting the spread of crop disease, the ongoing development of new such fungicides may be leaving people more vulnerable to severe infections, according to new commentary published in the New England Journal of Medicine. 'Antimicrobial resistant pathogens are a constant reminder for us to use agents judiciously,' lead author George Thompson, a professor of medicine at the University of California, Davis, said in a statement. 'We have learned that the widespread use of antibiotics for livestock resulted in the rapid development of resistance to antibacterials,' Thompson continued. 'We have similar concerns regarding the use of antifungals in the environment.' In the past few decades, fungi that cause severe infections in humans — such as the difficult-to-treat Candida auris — have undergone a rapid increase, the scientists noted. Yet because there are relatively few antifungals available to eradicate such microbes from the body, Thompson stressed that 'preventing resistance is of paramount importance.' In the U.S. today, the researchers found that there are about 75,000 hospitalizations and 9 million outpatient visits linked to fungal diseases every year, with direct annual costs amount to $6.7 billion to $7.5 billion. At the same time, the U.S. Department of Agriculture estimates that fungi cause between 10 percent to 20 percent of crop loss, at a cost of $100 billion to $200 billion annually, according to the report. However, scientists have now become increasingly aware that antifungal pesticides and antifungal drugs share some of the same mechanisms. The authors therefore warned that the promulgation of these chemicals 'may select for resistant fungi in the environment, which can then endanger human health.' The development of antifungal medications, meanwhile, is a difficult task due to the metabolic similarities shared by human and fungal cells, as well as the surge in antifungal resistance, the authors explained. Tackling this problem, they contended, requires what's known as a 'One Health' approach — a state that recognizes how human, animal and environmental health are all related. As scientists research future solutions, having representatives from each of these sectors in the room will be increasingly critical, the commentary argued. Shared decision-making among national and global regulators, the researchers added, would both be cost-effective and would help avoid the 'riskier prospects of the rapid spread of resistant pathogens.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

California scientists sound alarm on role of pesticides in raising resistance to antifungal drugs
California scientists sound alarm on role of pesticides in raising resistance to antifungal drugs

The Hill

time5 hours ago

  • The Hill

California scientists sound alarm on role of pesticides in raising resistance to antifungal drugs

The proliferation of new fungicides in the U.S. agricultural sector may be raising resistance to critical antifungal medications in humans and animals, infectious disease experts are warning. Although antifungal pesticides have become vital to combatting the spread of crop disease, the ongoing development of new such fungicides may be leaving people more vulnerable to severe infections, according to new commentary published in the New England Journal of Medicine. 'Antimicrobial resistant pathogens are a constant reminder for us to use agents judiciously,' lead author George Thompson, a professor of medicine at the University of California, Davis, said in a statement. 'We have learned that the widespread use of antibiotics for livestock resulted in the rapid development of resistance to antibacterials,' Thompson continued. 'We have similar concerns regarding the use of antifungals in the environment.' In the past few decades, fungi that cause severe infections in humans — such as the difficult-to-treat Candida auris — have undergone a rapid increase, the scientists noted. Yet because there are relatively few antifungals available to eradicate such microbes from the body, Thompson stressed that 'preventing resistance is of paramount importance.' In the U.S. today, the researchers found that there are about 75,000 hospitalizations and 9 million outpatient visits linked to fungal diseases every year, with direct annual costs amount to $6.7 billion to $7.5 billion. At the same time, the U.S. Department of Agriculture estimates that fungi cause between 10 percent to 20 percent of crop loss, at a cost of $100 billion to $200 billion annually, according to the report. However, scientists have now become increasingly aware that antifungal pesticides and antifungal drugs share some of the same mechanisms. The authors therefore warned that the promulgation of these chemicals 'may select for resistant fungi in the environment, which can then endanger human health.' The development of antifungal medications, meanwhile, is a difficult task due to the metabolic similarities shared by human and fungal cells, as well as the surge in antifungal resistance, the authors explained. Tackling this problem, they contended, requires what's known as a 'One Health' approach — a state that recognizes how human, animal and environmental health are all related. As scientists research future solutions, having representatives from each of these sectors in the room will be increasingly critical, the commentary argued. Shared decision-making among national and global regulators, the researchers added, would both be cost-effective and would help avoid the 'riskier prospects of the rapid spread of resistant pathogens.'

CPAP or Zepbound? Patients, doctors debate sleep apnea treatment
CPAP or Zepbound? Patients, doctors debate sleep apnea treatment

UPI

time6 hours ago

  • UPI

CPAP or Zepbound? Patients, doctors debate sleep apnea treatment

Doctors favor treatment with continuous positive airway pressure, or CPAP, machines, researchers are slated to report this week at a meeting of the American Academy of Sleep Medicine. Adobe stock June 9 (UPI) A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study reports. Doctors favor treatment with continuous positive airway pressure, or CPAP, machines, researchers are slated to report this week at a meeting of the American Academy of Sleep Medicine. The machines keep airways open using mild air pressure provided through a mask patients wear while sleeping. But patients would rather treat their sleep apnea with tirzepatide (Zepbound), a GLP-1 weight-loss drug, researchers found. "The results highlight a need for real-world comparative effectiveness data of CPAP versus tirzepatide, and a potential mismatch between patient and provider preferences when managing comorbid obesity and obstructive sleep apnea," lead researcher Ahmed Khalaf said in a news release. He's a sleep technician in the pulmonary, critical care and sleep medicine division at University of California-San Diego. Nearly 30 million adults in the United States have sleep apnea, a disease in which the upper airway collapses during sleep, causing people to wake repeatedly. CPAP has been considered the gold standard for treating sleep apnea, but some patients find the machines too bulky and noisy. About 50% of people prescribed CPAP either can't use it often enough to matter or find it too bothersome, according to Harvard Medical School. Common problems include mask discomfort, dry mouth, breathing that feels out of sync and noise from the machine. Late last year, the U.S. Food and Drug Administration approved Zepbound as the first drug to treat people with obesity and sleep apnea. At the time, the sleep medicine society hailed the approval as "a positive development for patients and clinicians, who now have another treatment option for this sleep disorder," according to a statement from the academy. But Zepbound is only for people with obesity and sleep apnea, the society noted. Also, Zepbound can reduce the severity of sleep apnea through weight loss, but might not cure the problem. For the new study, researchers analyzed nationwide online survey data from 365 patients, and also spoke to 17 sleep medicine professionals at UCSD. Doctors favored CPAP over Zepbound 53% to 26%, while patients favored Zepbound over CPAP 48% to 35%. Both doctors and patients supported treatment that combined CPAP and Zepbound, but doctors were more enthusiastic about combination therapy, 88% versus 61%. The patients' preferences are likely driven by their own experiences -- 78% said they were either current or former users of CPAP, results show. By comparison, only 23% of patients said they'd ever used Zepbound or Ozempic (semaglutide), the other prominent GLP-1 drug. Principal investigator Dr. Chris Schmickl, an assistant professor of medicine at University of California-San Diego, expressed surprise at the level of disagreement between patients and providers. "Recognizing differing attitudes toward treatment is crucial for developing a realistic and achievable action plan," he said in a news release. "Additional research to understand the underlying reasons behind these preferences will offer valuable insights for providers to guide treatment decisions." Researchers are scheduled to present these findings Wednesday at the society meeting in Seattle. Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal. More information Harvard Medical School has more on managing CPAP problems. Copyright © 2025 HealthDay. All rights reserved.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store